New phase 3a liraglutide 3 mg data showed weight-loss efficacy across a range of baseline BMI categories, and significant improvements in health-related quality of life… New data from the phase 3a SCALE™ (Satiety and Clinical Adiposity−Liraglutide Evidence in Non-diabetic and Diabetic people) Obesity and Pre-diabetes trial were presented at ObesityWeek. …

Citizens of Berkeley, California have voted for a tax on sugary drinks — a penny per ounce of soda, energy drink or sweetened tea — becoming the first city to pass such a tax in the U.S.. Proponents of the fee say it will help curb consumption of beverages contributing …

The National Pharmaceutical Council and Discern Health recently issued a report identifying gaps in accountable care quality measures and strategies for improvement. Suggestions include implementing outcome measures that are meaningful to patients and providers; that evaluate care across conditions, settings and time; and that matter most to patients, as well …

According to a new study using data from the 2007 – 2012 National Health and Nutrition Examination Survey, 140 million American adults should be considering behavioral weight-loss treatment, and 116 million of those are also candidates for pharmacotherapy. Of those recommended for both behavioral treatment and pharmacotherapy, 32 million may …

Manuka honey is produced in New Zealand by bees that pollinate the native manuka bush.

  The Beddit Sleep Monitor tracks patients’ sleep accurately without any disturbing wearable sensors. Patients can sleep directly on the sensor and it will measure heart rate, respiration, sleep cycles and sleep time. Beddit Sleep Tracker is based on ballistocardiography (BCG), a measure of ballistic forces on the heart. During …

  Novo Nordisk has launched the NovoRapid PumpCart, the first prefilled pump cartridge with an insulin analog that has been specifically designed for insulin pumps. The new treatment solution contains NovoRapid (insulin aspart) — a rapid-acting insulin. The 1.6 ml cartridge was developed in a non-exclusive partnership between Roche Diabetes Care …

Last week, my daughter was out for a 100 mile bike ride and at mile 78 she was coming down a bridge on Madera Beach at about 27 mph when a car cut in front of her to make a right turn. She braked very hard, hit some gravel and …

Every week we see patients who can’t tolerate metformin, and we often have to chose a less effective but more expensive medication for their diabetes. We try decreasing the dose and then titrating back up, and even that does not work. For years, pharmaceutical companies have been trying to find …

Rudy Bilous, MD, FRCP Richard Donnelly, MD, PHD, FRCP, FRACP Symptoms, signs and classification Diabetes is one of the most common causes of peripheral neuropathy, a term that encompasses a heterogeneous group of disorders (Figure 17.1). In population-based surveys, up to one-third of patients with diabetes have evidence of peripheral neuropathy but …